Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical experience with continuous flow and flow-through peritoneal dialysis.

R Amerling1, L DeSimone, R Inciong-Reyes

  • 1Beth Israel Medical Center, New York, New York 10003, USA. ramerling@bethisraelny.org

Seminars in Dialysis
|October 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

sRAGE: a prognostic factor for mortality in end-stage renal disease patients on dialysis.

Journal of biological regulators and homeostatic agents·2019
Same author

Elevated Levels of Procalcitonin and Interleukin-6 are Linked with Postoperative Complications in Cardiac Surgery.

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society·2017
Same author

Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.

Thrombosis research·2017
Same author

Pathophysiology of the cardio-renal syndromes types 1-5: An uptodate.

Indian heart journal·2017
Same author

The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients.

Critical care (London, England)·2016
Same author

Sudden cardiac death and chronic kidney disease: From pathophysiology to treatment strategies.

International journal of cardiology·2016

Continuous flow peritoneal dialysis (CFPD) shows promise for improving solute removal efficiency. While urea clearances were around 30 ml/min, dialysate flow limitations were observed, impacting overall effectiveness.

Area of Science:

  • Nephrology
  • Renal Replacement Therapy
  • Dialysis Technology

Background:

  • Conventional peritoneal dialysis (PD) faces challenges with solute removal inefficiency.
  • Renewed interest in continuous flow PD (CFPD) is driven by the need for more effective dialysis methods.

Purpose of the Study:

  • To present clinical data from two distinct experiences with continuous flow peritoneal dialysis (CFPD).
  • To evaluate the efficacy and potential of CFPD as an alternative dialysis modality.

Main Methods:

  • Two CFPD techniques were employed: a two-catheter recirculation system using hemodialysis equipment and a dual-lumen catheter for flow-through PD (FTPD).
  • Urea clearances were measured during both CFPD and FTPD sessions.

Main Results:

Related Experiment Videos

  • Urea clearances for both CFPD techniques averaged approximately 30 ml/min.
  • Significant dialysate streaming within the peritoneal cavity was identified as a factor limiting clearance efficiency.

Conclusions:

  • CFPD demonstrates potential as a safe and effective alternative to conventional home hemodialysis.
  • Further optimization of CFPD techniques is needed to overcome dialysate flow limitations and enhance solute removal.